Latest filing published 19 Aug 2024 for YIELD10 BIOSCIENCE, INC., €999. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Charles B. Haaser (senior executive) discloses dealings in Yield10 Bioscience, Inc. to SEC (Form 4). The record holds 8 filings, for trades running from 1 September 2021 to 15 August 2024.
The open-market record is one-sided, with 1 purchase worth €8,915 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 share grants.
The latest filing, published on 19 August 2024, reports a share grant of €999 in Yield10 Bioscience, Inc. The last purchase on record was published on 7 December 2021, which is 1,776 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations